Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/51143
Type
ArticleCopyright
Open access
Collections
- IOC - Artigos de Periódicos [12488]
Metadata
Show full item record
REIMAGINING LEPROSY ELIMINATION WITH AI ANALYSIS OF A COMBINATION OF SKIN LESION IMAGES WITH DEMOGRAPHIC AND CLINICAL DATA
Inteligência artificial
AI
Diagnóstico baseado em imagem
Dermatologia
Lesões de pele
Al4lepra
Artificial intelligence
AI
Image-based diagnosis
Dermatology
Skin lesions
Al4leprosy
Author
Barbieri, Raquel R.
Yixi, Xu
Setian, Lucy
Souza-Santos, Paulo Thiago
Trivedi, Anusua
Cristofono, Jim
Bhering, Ricardo
White, Kevin
Sales, Anna M.
Miller, Geralyn
Nery, José Augusto C.
Sharman, Michael
Bumann, Richard
Shun, Zhang
Goldust, Mohamad
Sarno, Euzenir N.
Mirza, Fareed
Cavaliero, Arielle
Timmer, Sander
Bonfiglioli, Elena
Smith, Cairns
Scollard, David
Navarini, Alexander A.
Aerts, Ann
Ferres, Juan Lavista
Moraes, Milton O.
Yixi, Xu
Setian, Lucy
Souza-Santos, Paulo Thiago
Trivedi, Anusua
Cristofono, Jim
Bhering, Ricardo
White, Kevin
Sales, Anna M.
Miller, Geralyn
Nery, José Augusto C.
Sharman, Michael
Bumann, Richard
Shun, Zhang
Goldust, Mohamad
Sarno, Euzenir N.
Mirza, Fareed
Cavaliero, Arielle
Timmer, Sander
Bonfiglioli, Elena
Smith, Cairns
Scollard, David
Navarini, Alexander A.
Aerts, Ann
Ferres, Juan Lavista
Moraes, Milton O.
Affilliation
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Rio de Janeiro, RJ, Brasil.
Microsoft, One Microsoft Way, One Microsoft Way. Redmond, WA, USA.
Novartis Foundation. Basel, Switzerland.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Rio de Janeiro, RJ, Brasil.
Microsoft, One Microsoft Way, One Microsoft Way. Redmond, WA, USA.
Microsoft, One Microsoft Way, One Microsoft Way. Redmond, WA, USA.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Rio de Janeiro, RJ, Brasil.
Microsoft, One Microsoft Way, One Microsoft Way. Redmond, WA, USA.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Rio de Janeiro, RJ, Brasil.
Microsoft, One Microsoft Way, One Microsoft Way. Redmond, WA, USA.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Rio de Janeiro, RJ, Brasil.
Microsoft, One Microsoft Way, One Microsoft Way. Redmond, WA, USA.
Microsoft, One Microsoft Way, One Microsoft Way. Redmond, WA, USA.
Microsoft, One Microsoft Way, One Microsoft Way. Redmond, WA, USA.
University of Basel. Basel. Switzerland / Department of Dermatology, University Medical Center Mainz. Mainz, German.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Rio de Janeiro, RJ, Brasil.
Novartis Foundation. Basel, Switzerland.
Novartis Foundation. Basel, Switzerland.
Microsoft, One Microsoft Way, One Microsoft Way. Redmond, WA, USA.
Microsoft, One Microsoft Way, One Microsoft Way. Redmond, WA, USA.
University of Aberdeen, Aberdeen, Scotland.
Retired, Wilbraham, MA, United States,
University of Basel. Basel. Switzerland
Novartis Foundation. Basel, Switzerland.
Microsoft, One Microsoft Way, One Microsoft Way. Redmond, WA, USA.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Rio de Janeiro, RJ, Brasil.
Microsoft, One Microsoft Way, One Microsoft Way. Redmond, WA, USA.
Novartis Foundation. Basel, Switzerland.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Rio de Janeiro, RJ, Brasil.
Microsoft, One Microsoft Way, One Microsoft Way. Redmond, WA, USA.
Microsoft, One Microsoft Way, One Microsoft Way. Redmond, WA, USA.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Rio de Janeiro, RJ, Brasil.
Microsoft, One Microsoft Way, One Microsoft Way. Redmond, WA, USA.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Rio de Janeiro, RJ, Brasil.
Microsoft, One Microsoft Way, One Microsoft Way. Redmond, WA, USA.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Rio de Janeiro, RJ, Brasil.
Microsoft, One Microsoft Way, One Microsoft Way. Redmond, WA, USA.
Microsoft, One Microsoft Way, One Microsoft Way. Redmond, WA, USA.
Microsoft, One Microsoft Way, One Microsoft Way. Redmond, WA, USA.
University of Basel. Basel. Switzerland / Department of Dermatology, University Medical Center Mainz. Mainz, German.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Rio de Janeiro, RJ, Brasil.
Novartis Foundation. Basel, Switzerland.
Novartis Foundation. Basel, Switzerland.
Microsoft, One Microsoft Way, One Microsoft Way. Redmond, WA, USA.
Microsoft, One Microsoft Way, One Microsoft Way. Redmond, WA, USA.
University of Aberdeen, Aberdeen, Scotland.
Retired, Wilbraham, MA, United States,
University of Basel. Basel. Switzerland
Novartis Foundation. Basel, Switzerland.
Microsoft, One Microsoft Way, One Microsoft Way. Redmond, WA, USA.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Rio de Janeiro, RJ, Brasil.
Abstract
Leprosy is an infectious disease that mostly affects underserved populations. Although it has been
largely eliminated, still about 200’000 new patients are diagnosed annually. In the absence of a diagnostic test, clin-
ical diagnosis is often delayed, potentially leading to irreversible neurological damage and its resulting stigma, as
well as continued transmission. Accelerating diagnosis could significantly contribute to advancing global leprosy
elimination. Digital and Artificial Intelligence (AI) driven technology has shown potential to augment health work-
ers abilities in making faster and more accurate diagnosis, especially when using images such as in the fields of der-
matology or ophthalmology. That made us start the quest for an AI-driven diagnosis assistant for leprosy, based on
skin images.
Keywords in Portuguese
HanseníaseInteligência artificial
AI
Diagnóstico baseado em imagem
Dermatologia
Lesões de pele
Al4lepra
Keywords
LeprosyArtificial intelligence
AI
Image-based diagnosis
Dermatology
Skin lesions
Al4leprosy
Share